Indivior PLC INDV-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 4:35 PM BST
212.80quote price arrow down-3.20 (-1.48%)
52 week range
67.00 - 221.00
Loading...
  • Open215.80
  • Day High216.60
  • Day Low209.60
  • Prev Close216.00
  • 52 Week High221.00
  • 52 Week High Date09/23/21
  • 52 Week Low67.00
  • 52 Week Low Date11/27/20

Key Stats

  • Market Cap2,171.35M
  • Shares Out734.84M
  • 10 Day Average Volume1.89M
  • Dividend-
  • Dividend Yield-
  • Beta-0.68
  • YTD % Change95.59

KEY STATS

  • Open215.80
  • Day High216.60
  • Day Low209.60
  • Prev Close216.00
  • 52 Week High221.00
  • 52 Week High Date09/23/21
  • 52 Week Low67.00
  • 52 Week Low Date11/27/20
  • Market Cap2,171.35M
  • Shares Out734.84M
  • 10 Day Average Volume1.89M
  • Dividend-
  • Dividend Yield-
  • Beta-0.68
  • YTD % Change95.59

RATIOS/PROFITABILITY

  • EPS (TTM)13.20
  • P/E (TTM)16.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/16/2016
  • Div Amount7.30
  • Split Date-
  • Split Factor-

Latest On Indivior PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine...
Graham Hetherington
Non-Executive Chairman
Mark Crossley
Chief Executive Officer
Ryan Preblick
Chief Financial Officer
Address
234 Bath Road
Slough
SL1 4EE
United Kingdom